Our finding suggested that SFXN4 was upregulated in HCC, predicted poor prognosis, and may facilitate HCC development and progression via various mechanisms, indicating SFXN4 may provide both prognostic information and therapeutic potential for HCC. This evidence concerns the gene SFXN4 and hepatocellular carcinoma.